Jensen, Benny Vittrup <br/><br/>
High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2003 
 - 4423-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipokines<br/>Adult<br/>Aged<br/>Autoantigens--blood<br/>Biomarkers, Tumor--blood<br/>Breast Neoplasms--blood<br/>Chitinase-3-Like Protein 1<br/>Female<br/>Glycoproteins--blood<br/>Humans<br/>Lectins<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Prognosis<br/>Prospective Studies<br/>Receptor, ErbB-2--blood<br/>Receptors, Estrogen--metabolism<br/>Survival Rate